Ion Beam Applications SA (EBR:IBAB)
Belgium · Delayed Price · Currency is EUR 16.00
-0.46 (-2.79%)
Oct 30, 2026, 5:35 PM CET
Ion Beam Applications Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 639 | 620.18 | 498.16 | 466.67 | 361.27 | 312.96 |
Revenue Growth | 3.03% | 24.49% | 6.75% | 29.17% | 15.43% | 0.32% |
Gross Profit Gross Profit Growth | 218.54 | 199.62 | 168.09 | 134.44 | 126.77 | 107.69 |
Operating Income Operating Income Growth | 40.58 | 34.73 | 28.1 | 7.61 | 9.45 | 13.67 |
Net Income Net Income Growth | 24.61 | 12.73 | 9.25 | -9.11 | 6.06 | 3.88 |
Earnings Per Share EPS Growth | 0.80 | 0.42 | 0.31 | -0.31 | 0.20 | 0.13 |
EPS Growth | 90.11% | 33.94% | - | - | 56.07% | -88.03% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Clinical Proton Therapy Clinical Proton Therapy Growth | 347.21 | 334.34 | 212.83 | - | - | - |
IBA Clinical - Dosimetry IBA Clinical - Dosimetry Growth | 61.72 | 65.69 | 65.88 | 65.91 | 53.97 | 52.33 |
IBA Technologies IBA Technologies Growth | 236.38 | 224.86 | 223.53 | - | - | - |
Eliminations Eliminations Growth | -6.3 | -4.72 | -4.09 | -3.62 | -1.53 | - |
Total Total Growth | 639 | 620.18 | 498.16 | 466.67 | 361.27 | 312.96 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 43.81 | 65.25 | 72.59 | 109.62 | 169.5 | 199.27 |
Total Debt Total Debt Growth | 118.79 | 116.89 | 43.69 | 41.58 | 40.87 | 68.98 |
Net Cash (Debt) Net Cash Growth | -74.97 | -51.64 | 28.89 | 68.03 | 128.64 | 130.29 |
Net Cash Growth | - | - | -57.53% | -47.11% | -1.27% | 92.22% |
Net Cash Per Share Net Cash Per Share Growth | -2.43 | -1.70 | 0.98 | 2.34 | 4.26 | 4.32 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4.55 | -25.67 | -10.59 | -19.77 | 21.71 | 87.21 |
Capital Expenditures CapEx Growth | -7.35 | -9.32 | -4.28 | -5.27 | -3.23 | -4.25 |
Free Cash Flow Free Cash Flow Growth | -2.81 | -34.99 | -14.87 | -25.03 | 18.48 | 82.97 |
Free Cash Flow Growth | - | - | - | - | -77.72% | -15.23% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.20% | 32.19% | 33.74% | 28.81% | 35.09% | 34.41% |
Operating Margin | 6.35% | 5.60% | 5.64% | 1.63% | 2.62% | 4.37% |
Pretax Margin | 4.67% | 3.03% | 2.99% | -0.07% | -0.12% | 2.64% |
Profit Margin | 3.85% | 2.05% | 1.86% | -1.95% | 1.68% | 1.24% |
FCF Margin | -0.44% | -5.64% | -2.99% | -5.36% | 5.12% | 26.51% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.250 | 0.250 | 0.240 | 0.170 | 0.210 | 0.190 |
Dividend Per Share Growth | 4.17% | 4.17% | 41.18% | -19.05% | 10.53% | -5.00% |
Dividend Yield | 1.56% | 1.94% | 1.80% | 1.47% | 1.35% | 1.26% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.02 | 29.70 | 42.32 | - | 74.89 | 114.02 |
Forward PE | 19.82 | 8.54 | 15.77 | 65.94 | 35.16 | 76.20 |
P/FCF Ratio | - | - | - | - | 24.55 | 5.33 |
PS Ratio | 0.73 | 0.61 | 0.79 | 0.72 | 1.26 | 1.41 |